| RS1469574477 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BRCA2-related cancer predisposition |
| RS146960286 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS146960401 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, VPS13B-related disorder |
| RS1469620436 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS146962414 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMB2-related disorder, Pierson syndrome |
| RS146962984 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Otospondylomegaepiphyseal dysplasia, autosomal recessive |
| RS146963107 |
SLC3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |
| RS146963572 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, Inborn genetic diseases |
| RS146964054 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS146965005 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS1469652745 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS146965680 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12 |
| RS146967918 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Walker-Warburg congenital muscular dystrophy |
| RS146967928 |
ATP6V0A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, Inborn genetic diseases |
| RS146967957 |
PLS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PLS1-related disorder |
| RS146968459 |
GDF5
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS146968493 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS146969255 |
PIGV
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 1, Hyperphosphatasia with intellectual disability syndrome 1 |
| RS1469699202 |
MPV17
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Charcot-Marie-Tooth disease |
| RS146970014 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS146970027 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS146970233 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146970674 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1469708148 |
SPTB
|
Health Risk |
Pathogenic |
— |
| RS1469711487 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS1469714335 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Gastric cancer |
| RS146971634 |
SLC35C1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukocyte adhesion deficiency type II, Inborn genetic diseases |
| RS146971652 |
C1QTNF5;MFRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 5, Late-onset retinal degeneration |
| RS146971757 |
CFAP43
|
Health Risk |
Conflicting classifications of pathogenicity |
CFAP43-related disorder, CFAP43-related disorder |
| RS1469729130 |
VPS13B
|
Health Risk |
Pathogenic |
Global developmental delay, Retinal dystrophy |
| RS1469730786 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Cardiomyopathy |
| RS146973564 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS146973734 |
GDF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 7, Microphthalmia |
| RS146973799 |
AGPAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 1, AGPAT2-related disorder |
| RS1469739934 |
MPL
|
Health Risk |
Pathogenic |
Congenital amegakaryocytic thrombocytopenia, Essential thrombocythemia |
| RS146974265 |
NEUROG3
|
Health Risk |
Conflicting classifications of pathogenicity |
NEUROG3-related disorder, Inborn genetic diseases |
| RS146975341 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS146975768 |
FANCF
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group F |
| RS1469760018 |
RPGR
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS146976290 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS146976547 |
POC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome, Inborn genetic diseases |
| RS146976856 |
EPB41
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 1, Elliptocytosis 1 |
| RS146976883 |
TOR1AIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, TOR1AIP1-related disorder |
| RS146977165 |
FBN3
|
Health Risk |
Conflicting classifications of pathogenicity |
FBN3-related disorder, FBN3-related disorder |
| RS146977269 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1J, Autosomal dominant nonsyndromic hearing loss 10 |
| RS146977278 |
PRICKLE3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146977539 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS146978168 |
GALNT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS1469787406 |
COL11A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Fibrochondrogenesis 1, Marshall syndrome |
| RS146980198 |
COL10A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, COL10A1-related disorder |
| RS146980624 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS146980702 |
ADAM9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 9, ADAM9-related disorder |
| RS146982082 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS146982102 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS146982209 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS146982282 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1469836617 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS146986015 |
SPG21
|
Health Risk |
Conflicting classifications of pathogenicity |
Mast syndrome, Hereditary spastic paraplegia |
| RS1469863276 |
NPHS2
|
Health Risk |
Pathogenic |
— |
| RS1469878578 |
SOX11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypogonadotropic hypogonadism |
| RS146988096 |
KRT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146988468 |
FARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS1469887040 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS146989944 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS146990068 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, ABCA12-related disorder |
| RS1469902314 |
TPP1
|
Health Risk |
Pathogenic |
— |
| RS1469902667 |
ATP1A2
|
Health Risk |
Pathogenic |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS146990317 |
DLL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS146990376 |
SHH
|
Health Risk |
Pathogenic |
Holoprosencephaly 3, Holoprosencephaly 3 |
| RS146990448 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS146990471 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146990608 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya disease 2, Moyamoya disease 2 |
| RS1469912999 |
PIGB
|
Health Risk |
Likely pathogenic |
— |
| RS1469916243 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Central core myopathy |
| RS1469917649 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1469918162 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS1469919677 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS146993090 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS1469935655 |
MYO18B
|
Health Risk |
Pathogenic |
— |
| RS1469938477 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146993892 |
CLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 5 |
| RS146994573 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary xanthinuria type 1, Xanthinuria type II |
| RS146995242 |
PRPF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, PRPF3-related disorder |
| RS1469952990 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1469961964 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1469962264 |
HPSE2
|
Health Risk |
Pathogenic |
Urofacial syndrome type 1, Urofacial syndrome type 1 |
| RS146996627 |
TNRC6B
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS146997233 |
CD3D
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 19, Immunodeficiency 19 |
| RS1469975894 |
CC2D2A
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS146997967 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1469983269 |
MAP3K20
|
Health Risk |
Pathogenic |
— |
| RS1469986980 |
TGFBR2
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Diabetic retinopathy, Diabetic retinopathy |
| RS1469992138 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS146999462 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS146999911 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1J, Cardiovascular phenotype |
| RS147000344 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Inborn genetic diseases |
| RS147000526 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Woolly hair-skin fragility syndrome |
| RS147000685 |
LRPPRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS147000954 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS147001219 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |